Persistently high body mass index (≥23 kg/m²) significantly reduced the risk of extended major adverse cardiovascular events (RR 0.279) compared to consistently low BMI in patients with CKD.
Cohort
Yes
Does sustained high BMI reduce extended major adverse cardiovascular events in patients with chronic kidney disease?
Adults with chronic kidney disease (CKD stages G1-G5 non-dialysis), mean age 53.9 years, 59.8% male.
Sustained high BMI (≥ 23 kg/m2) over a 7-year period.
Consistently low BMI (< 23 kg/m2) over a 7-year period.
Extended major adverse cardiovascular events (eMACEs), a composite of acute myocardial infarction, hospitalization for unstable angina or heart failure, percutaneous coronary interventions, coronary artery bypass grafting, ischemic or hemorrhagic stroke, symptomatic arrhythmias requiring hospitalization, peripheral arterial disease, and other cardiovascular events necessitating hospitalization or intervention.composite
Sustained high BMI over a 7-year period is associated with a significantly reduced risk of major adverse cardiovascular events in patients with chronic kidney disease, supporting the obesity paradox in this population.
The relationship between body mass index (BMI) and cardiovascular outcomes in chronic kidney disease (CKD) remains controversial. While the obesity paradox has been observed in this population, the impact of longitudinal BMI patterns over time is not well established. In this study, we investigated the association between BMI trajectories and the risk of cardiovascular events (CVEs) using data from 1061 patients enrolled in the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD). BMI was categorized as high (≥ 23 kg/m2) or low (< 23 kg/m2), and assessed at three time points over a 7-year period. We applied targeted maximum likelihood estimation (TMLE) and marginal structural models (MSMs) to adjust for time-varying covariates, including estimated glomerular filtration rate, blood pressure, hemoglobin, albumin, and C-reactive protein, as well as baseline demographic and clinical characteristics. Patients with persistently high BMI had a significantly reduced risk of CVEs (relative risk 0.279; 95% CI 0.143–0.546; P < 0.001) compared to those with consistently low BMI. Transient increases or decreases in BMI did not show the same benefit. Our findings suggest that sustained high BMI may be protective against cardiovascular events in patients with CKD, challenging current weight management recommendations and supporting individualized approaches based on long-term risk profiles.
Building similarity graph...
Analyzing shared references across papers
Loading...
Oh et al. (Fri,) conducted a cohort in Chronic kidney disease (n=1,061). Persistently high BMI (≥23 kg/m²) vs. Consistently low BMI (<23 kg/m²) was evaluated on Extended major adverse cardiovascular events (eMACEs) (RR 0.279, 95% CI 0.143-0.546, p=<0.001). Persistently high body mass index (≥23 kg/m²) significantly reduced the risk of extended major adverse cardiovascular events (RR 0.279) compared to consistently low BMI in patients with CKD.
www.synapsesocial.com/papers/69bf86ecf665edcd009e90a4 — DOI: https://doi.org/10.1038/s41598-026-45135-7
Yun Jung Oh
Jayoun Kim
Suah Sung
Scientific Reports
Seoul National University Hospital
Chonnam National University
Gachon University
Building similarity graph...
Analyzing shared references across papers
Loading...